<ENAMEX TYPE="ORGANIZATION">Baxter International Inc.</ENAMEX> said that <ENAMEX TYPE="ORGANIZATION">Utah Medical Products Inc.</ENAMEX> will buy back 300,000 <ENAMEX TYPE="LOCATION">Utah</ENAMEX> Medical common shares at $4 each.
As part of an agreement in principle, <ENAMEX TYPE="ORGANIZATION">Utah Medical</ENAMEX> will also buy back from <ENAMEX TYPE="ORGANIZATION">Baxter</ENAMEX> for $1,350,000 warrants to acquire <ENAMEX TYPE="ORGANIZATION">675,000 Utah Medical</ENAMEX> common shares. The agreement was summarized in a <ENAMEX TYPE="ORGANIZATION">Securities and Exchange Commission</ENAMEX> filing.
According to the filing, <ENAMEX TYPE="ORGANIZATION">Baxter</ENAMEX> currently controls 1,325,000 <ENAMEX TYPE="ORGANIZATION">Utah Medical</ENAMEX> common shares, or the equivalent of 15.9%.
<ENAMEX TYPE="ORGANIZATION">Baxter</ENAMEX>, of <ENAMEX TYPE="LOCATION">Deerfield</ENAMEX>, <ENAMEX TYPE="LOCATION">Ill.</ENAMEX>, is a medical care products concern. <ENAMEX TYPE="LOCATION">Utah</ENAMEX> Medical is based in <ENAMEX TYPE="LOCATION">Midvale</ENAMEX>, <ENAMEX TYPE="LOCATION">Utah</ENAMEX>.
A second agreement in principle reached between the two companies concerns certain aspects of the purchase and supply agreements between the companies and provides for payments by <ENAMEX TYPE="ORGANIZATION">Baxter</ENAMEX> to <ENAMEX TYPE="ORGANIZATION">Utah Medical</ENAMEX> of $757,720.
